|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-4-23
|
|
pubmed:abstractText |
Menopause diminishes insulin secretion and elimination, increases risk of diabetes and adversely affects lipoprotein metabolism. This study was undertaken to establish whether oral oestradiol plus dydrogesterone postmenopausal hormone therapy can modify these changes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
541-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15104556-Adult,
pubmed-meshheading:15104556-Aged,
pubmed-meshheading:15104556-Analysis of Variance,
pubmed-meshheading:15104556-Blood Glucose,
pubmed-meshheading:15104556-C-Peptide,
pubmed-meshheading:15104556-Cholesterol,
pubmed-meshheading:15104556-Double-Blind Method,
pubmed-meshheading:15104556-Drug Administration Schedule,
pubmed-meshheading:15104556-Dydrogesterone,
pubmed-meshheading:15104556-Estradiol,
pubmed-meshheading:15104556-Estrogen Replacement Therapy,
pubmed-meshheading:15104556-Female,
pubmed-meshheading:15104556-Humans,
pubmed-meshheading:15104556-Insulin,
pubmed-meshheading:15104556-Middle Aged,
pubmed-meshheading:15104556-Postmenopause,
pubmed-meshheading:15104556-Triglycerides
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women.
|
|
pubmed:affiliation |
Endocrinology and Metabolic Medicine, Faculty of Medicine, Imperial College London, London, UK. i.godsland@imperial.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
